146 related articles for article (PubMed ID: 26616116)
21. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract][Full Text] [Related]
23.
Zhou J; Yang X; Song P; Wang H; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305
[No Abstract] [Full Text] [Related]
24. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
25. Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer.
Qu Y; Zhang C; Du E; Wang A; Yang Y; Guo J; Wang A; Zhang Z; Xu Y
Med Sci Monit; 2016 Nov; 22():4254-4260. PubMed ID: 27826135
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
[TBL] [Abstract][Full Text] [Related]
28. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer.
Shen H; Zhang L; Zhou J; Chen Z; Yang G; Liao Y; Zhu M
Med Sci Monit; 2017 Jan; 23():216-222. PubMed ID: 28085790
[TBL] [Abstract][Full Text] [Related]
29. Gene expression of Aurora kinases in prostate cancer and nodular hyperplasia tissues.
Nna E; Madukwe J; Egbujo E; Obiorah C; Okolie C; Echejoh G; Yahaya A; Adisa J; Uzoma I
Med Princ Pract; 2013; 22(2):138-43. PubMed ID: 23075505
[TBL] [Abstract][Full Text] [Related]
30. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
[TBL] [Abstract][Full Text] [Related]
31. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance].
Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911
[TBL] [Abstract][Full Text] [Related]
32. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
33. Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer.
Chen IC; Chang YC; Lu YS; Chung KP; Huang CS; Lu TP; Kuo WH; Wang MY; Kuo KT; Wu PF; Hsueh TH; Shen CY; Lin CH; Cheng AL
Sci Rep; 2016 Feb; 6():21374. PubMed ID: 26877155
[TBL] [Abstract][Full Text] [Related]
34. Elevated CISD2 expression predicts poor diagnosis and promotes invasion and migration of prostate cancer cells.
Zhu QQ; Tian L; Li DL; Wu ZH; He YY; Zhang HK
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6597-6604. PubMed ID: 32633348
[TBL] [Abstract][Full Text] [Related]
35. Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
Carozzi F; Tamburrino L; Bisanzi S; Marchiani S; Paglierani M; Di Lollo S; Crocetti E; Buzzoni C; Burroni E; Greco L; Baldi E; Sani C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):201-12. PubMed ID: 26210155
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
37. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
38. Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
Sun J; Ling B; Xu X; Ma R; Li G; Cao X; Ling W; Yang Z; Hoffman RM; Lu J
Anticancer Res; 2016 Mar; 36(3):869-75. PubMed ID: 26976973
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
[TBL] [Abstract][Full Text] [Related]
40. DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
Zhang S; Zhang G; Guo H
Tumour Biol; 2017 Jun; 39(6):1010428317703822. PubMed ID: 28621231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
